Historically, SMPX has always been considered to be an NSHL gene because in human patients no other relevant symptoms have been associated with its mutations [1,2,3,18,19,20,21,22,23,24,25]. This evidence concerns the gene SMPX and nodular sclerosis classical Hodgkin lymphoma.